AI and Precision Oncology Innovations in Diagnosis and Drug Development

Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran , India. He completed his M.Pharm in Pharmaceutics from Galgotias University, Greater Noida. His research interests include nano-formulation, blockchain, IoT, machine learning, artificial intelligence, big data analytics, cancer biology, and neuroscience. He has contributed to academic books and book chapters and has published review articles in the areas of pharmaceutical sciences and healthcare technology. His work focuses on interdisciplinary approaches integrating pharmaceutical research with emerging digital and computational technologies.

Prateek Agrawal is professor and deputy dean at the School of Computer Science & Engineering, Lovely Professional University, Phagwara, Punjab, India. His research areas include natural language processing, computer vision, video processing, expert systems, deep learning applications, and other related topics. He is a senior member of IEEE and core member of IEEE India Council for Sustainable Development Activity, and is also a member of different reputed organizations like IET, MIR lab, and IAENG among others. Dr. Agarwal has published over 70 research papers in Scopus/SCIE indexed journals and conferences, 60 national patents, five edited books, and 10 book chapters. He is book series editor of the IOP series on next generation computing, and is a reviewer for many SCIE journals like Multimedia tools and Applications, Plos One, PeerJ, Oxford computer science, IEEE Access, and Ambient Intelligent & Humanized Computing.

Dr. Niraj Kumar Jha is an Assistant Professor of Biotechnology at Galgotias University, India, with prior research affiliations at the Centre for Research Impact & Outcome (CRIO), Chitkara University, and Sharda University. His research portfolio encompasses over 200 peer-reviewed articles and scholarly reviews, along with an edited volume published by Springer, reflecting sustained contributions to biomedical research and translational science. According to Scopus metrics, Dr. Jha’s publications have garnered more than 10,000 citations, with an H-index exceeding 50, underscoring the broad impact and visibility of his work within the global scientific community. He is an elected Member of the Royal Society of Biology (MRSB), London, and has been recognized among the World’s Top 2% Scientists in rankings compiled by Elsevier in collaboration with Stanford University. Dr. Jha actively contributes to scientific publishing and peer review as an associate editor for the Journal of Alzheimer’s Disease (IOS Press) and IET Nanobiotechnology (Wiley) and serves on the editorial boards of several international journals, including Scientific Reports. His research is centered on elucidating the molecular and cellular mechanisms underlying complex diseases such as neurodegenerative disorders, cancer, and cardiovascular pathologies. His work particularly emphasizes the modulation of key signaling pathways and explores the therapeutic potential of natural products, phytochemicals, and synthetic small molecules in disease intervention.